Abstract:OBJECTIVE: Adiponectin, one of the hormones secreted from adipose tissues, has effects on many physiological systems and metabolism pathways and is closely related to many diseases. To review and analyze the relationship between adiponectin and bone metabolism. DATA SOURCES: The related articles were searched in Medline between January 1995 and July 2006 with the of "adiponectin, bone" and "adiponectin, bone mineral density" in English. STUDY SELECTION: After the first check up the articles about clinical or basic studies of adiponectin were selected and the obviously unrelated articles were excluded. The full texts of the rest articles were searched for to further judge whether they were accordant with the inclusive criteria: ①basis studies, and ② clinical research relevant to human disease. DATA EXTRACTION:Totally163 articles were related to adiponectin in which were cited on the basis of the quality of experimental studies, and these studies 78 relevance to human disease, including 12 articles about the summary of adiponectin, 33 about the study of adiponectin and bone metabolism, and a total of 31 closely related and representative articles were reviewed. DATA SYNTHESIS:①Adiponectin, an adipocyte-derived hormone, possessed anti-hyperglycemic, anti-atherogenic, and anti-inflammatory properties because of its influence on glucose and lipid metabolism. ②In vitro and animal studies showed that adiponectin increased bone mass by suppressing osteoclastogenesis and possibly by activating osteoblasto-genesis, adiponectin actions on bone formation through three distinct pathways: a positive action through the autocrine/paracrine pathway by locally produced adiponectin, a negative action through the direct pathway by circulating adiponectin, and a positive action through the indirect pathway by circulating adiponectin via enhancement of the insulin signaling. Human cross-sectional studies about the role of adiponectin in bone metabolism also were not conclusive. ③Although some authors had reported a negative association between serum leptin levels and bone mineral density (BMD), others failed to find any relationship. CONCLUSION: Adiponectin, one of the hormones secreted from adipose tissues, is initially proposed to possess anti-hyperglycemic, anti-atherogenic, and anti-inflammatory properties because of its influence on glucose and lipid metabolism. Now, it is realized that adiponectin is involved in bone metabolism by affecting the activities of osteoblasts and osteoclasts by 3 different pathways of internal secretion and paracrine secretion. More basic and clinical studies are necessary to consolidate adiponectin's role in the physiology of bone tissues. In a word, the correlation of adiponectin with bone transformation and BMD provides some new directions for the prevention and treatment of bone metabolism associated diseases.

Adiponectin Deficiency Triggers Bone Loss by Up-Regulation of Osteoclastogenesis and Down-Regulation of Osteoblastogenesis

Adiponectin Regulates Bone Marrow Mesenchymal Stem Cell Niche Through a Unique Signal Transduction Pathway: an Approach for Treating Bone Disease in Diabetes

Adiponectin Exerts Its Negative Effect on Bone Metabolism Via OPG/RANKL Pathway: an in Vivo Study.

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways

Effects of Adiponectin on Osteoclastogenesis from Mouse Bone Marrow-Derived Monocytes

Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.

Aging alters the effect of adiponectin receptor signaling on bone marrow‐derived mesenchymal stem cells

Adiponectin Stimulates Human Osteoblasts Proliferation and Differentiation Via the Mapk Signaling Pathway

Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity.

Effects of adiponectin during bone metabolism

Deficiency Of Adiponectin Protects Against Ovariectomy-Induced Osteoporosis In Mice

Short-term caloric restriction induced bone loss in both axial and appendicular bones by increasing adiponectin

[Adiponectin Regulates the Expression of Osteoprotegerin and Receptor Activator of Nuclear Factor-Kappab Ligand in Human Osteoblast].

Adiponectin regulates the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand in human osteoblast

Effect of adiponectin on the expression of osteoprotegerin and receptor activator of nuclear factor-kappa B ligand in osteoblasts

Adiponectin overexpression promotes fracture healing through regulating the osteogenesis and adipogenesis balance in osteoporotic mice

Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis

[Effect of Adiponectin on Human Osteoblast Differentiation].

Central Adiponectin Administration Reveals New Regulatory Mechanisms of Bone Metabolism in Mice.

Aerobic exercise training-induced bone and vascular adaptations in mice lacking adiponectin

Adiponectin Inhibits Osteoclastogenesis by Suppressing NF-κB and P38 Signaling Pathways.